3D-QSAR study of c-Src kinase inhibitors based on docking

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• Cancer remains a major global health challenge, necessitating novel therapeutic strategies.
• The c-Src kinase is a promising target for developing new anticancer drugs.
• Existing research has identified several series of c-Src inhibitors with demonstrated activity.

Purpose of the Study:

• To build and validate 3D-QSAR (Quantitative Structure-Activity Relationship) models for anilinoquinazoline and quinolinecarbonitrile derivative inhibitors of c-Src.
• To explore structure-activity relationships and guide the design of new, potent c-Src inhibitors.

Main Methods:

• Utilized Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) to develop 3D-QSAR models.
• Employed docking simulations, including a flexible docking approach with the DOCK program, to determine inhibitor binding conformations.
• Validated models using statistical parameters like q² (predictivity) and r² (goodness of fit).

Main Results:

• Developed statistically significant 3D-QSAR models with high predictive power (CoMFA: q²=0.590, r²=0.855; CoMSIA: q²=0.538, r²=0.748).
• Docking simulations provided insights into c-Src kinase-inhibitor binding interactions.
• QSAR models based on flexible docking conformations also showed significant predictive ability (CoMFA: q²=0.507, r²=0.695; CoMSIA: q²=0.463, r²=0.734).

Conclusions:

• The developed QSAR models effectively elucidate structure-activity relationships for c-Src inhibitors.
• These models serve as valuable tools for the rational design of novel anticancer agents with improved efficacy and diversity.
• The findings contribute to the ongoing efforts in discovering efficient therapies for cancer.